pI: 4.4753 |
Length (AA): 294 |
MW (Da): 30237 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 294 | 5uav (A) | 0 | 273 | 30.00 | 0.00000000015 | 1 | 1.262 | 0.52 |
6 | 292 | 3tri (A) | 4 | 271 | 36.00 | 0 | 1 | 1.33879 | 0.07 |
6 | 41 | 2uyy (A) | 268 | 303 | 25.00 | 0.9 | 0.08 | 0.283649 | 0.81 |
8 | 122 | 5ocm (A) | 6 | 126 | 34.00 | 0.035 | 1 | 0.739756 | -0.19 |
8 | 290 | 5uav (A) | 3 | 269 | 37.00 | 0 | 1 | 1.22819 | 0.54 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126801)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G14800 | Pyrroline-5-carboxylate reductase |
Brugia malayi | Bm1_38015 | pyrroline-5-carboxylate reductase family protein |
Candida albicans | CaO19.5650 | Delta-1-pyrroline-5-carboxylate reductase |
Candida albicans | CaO19.13095 | Delta-1-pyrroline-5-carboxylate reductase |
Caenorhabditis elegans | CELE_M153.1 | Protein M153.1 |
Cryptosporidium hominis | Chro.60426 | pyrroline-5-carboxylate reductase |
Cryptosporidium parvum | cgd6_3720 | pyrroline-5-carboxylate reductase |
Dictyostelium discoideum | DDB_G0269410 | PCA reductase |
Dictyostelium discoideum | DDB_G0288671 | PCA reductase |
Drosophila melanogaster | Dmel_CG6009 | Pyrroline 5-carboyxlate reductase |
Drosophila melanogaster | Dmel_CG5840 | Pyrroline-5-carboxylate reductase-like 2 |
Escherichia coli | b0386 | pyrroline-5-carboxylate reductase, NAD(P)-binding |
Echinococcus granulosus | EgrG_000233100 | pyrroline 5 carboxylate reductase |
Echinococcus multilocularis | EmuJ_000233100 | pyrroline 5 carboxylate reductase |
Homo sapiens | ENSG00000104524 | pyrroline-5-carboxylate reductase-like |
Homo sapiens | ENSG00000183010 | pyrroline-5-carboxylate reductase 1 |
Leishmania braziliensis | LbrM.13.1540 | pyrroline-5-carboxylate reductase |
Leishmania donovani | LdBPK_131420.1 | pyrroline-5-carboxylate reductase |
Leishmania infantum | LinJ.13.1420 | pyrroline-5-carboxylate reductase |
Leishmania major | LmjF.13.1680 | pyrroline-5-carboxylate reductase |
Leishmania mexicana | LmxM.13.1680 | pyrroline-5-carboxylate reductase |
Loa Loa (eye worm) | LOAG_07911 | hypothetical protein |
Mycobacterium leprae | ML2430c | PROBABLE PYRROLINE-5-CARBOXYLATE REDUCTASE PROC (P5CR) (P5C REDUCTASE) |
Mus musculus | ENSMUSG00000022571 | pyrroline-5-carboxylate reductase-like |
Mus musculus | ENSMUSG00000025140 | pyrroline-5-carboxylate reductase 1 |
Mus musculus | ENSMUSG00000026520 | pyrroline-5-carboxylate reductase family, member 2 |
Mycobacterium tuberculosis | Rv0500 | Probable pyrroline-5-carboxylate reductase ProC (P5CR) (P5C reductase) |
Mycobacterium ulcerans | MUL_4570 | pyrroline-5-carboxylate reductase |
Neospora caninum | NCLIV_050390 | Pyrroline-5-carboxylate reductase (EC 1.5.1.2), related |
Oryza sativa | 4325755 | Os01g0948400 |
Plasmodium berghei | PBANKA_1134200 | pyrroline-5-carboxylate reductase, putative |
Plasmodium falciparum | PF3D7_1357900 | pyrroline-5-carboxylate reductase |
Plasmodium knowlesi | PKNH_1113600 | pyrroline-5-carboxylate reductase, putative |
Plasmodium vivax | PVX_114870 | pyrroline carboxylate reductase, putative |
Plasmodium yoelii | PY02938 | pyrroline-5-carboxylate reductase |
Saccharomyces cerevisiae | YER023W | pyrroline-5-carboxylate reductase |
Schistosoma japonicum | Sjp_0303670 | ko:K00286 pyrroline-5-carboxylate reductase [EC1.5.1.2], putative |
Schistosoma mansoni | Smp_049390 | pyrroline-5-carboxylate reductase |
Schmidtea mediterranea | mk4.015283.01 | |
Schmidtea mediterranea | mk4.023354.00 | Pyrroline-5-carboxylate reductase |
Trypanosoma brucei gambiense | Tbg972.7.2720 | pyrroline-5-carboxylate reductase, putative |
Trypanosoma brucei | Tb927.7.2440 | pyrroline-5-carboxylate reductase, putative |
Trypanosoma congolense | TcIL3000_7_1750 | pyrroline-5-carboxylate reductase, putative |
Trypanosoma cruzi | TcCLB.509207.90 | pyrroline-5-carboxylate reductase, putative |
Trypanosoma cruzi | TcCLB.506857.20 | pyrroline-5-carboxylate reductase, putative |
Toxoplasma gondii | TGME49_236070 | pyrroline-5-carboxylate reductase |
Treponema pallidum | TP0797 | 1-pyrroline-5-carboxylate reductase (proC) |
Trichomonas vaginalis | TVAG_423640 | pyrroline-5-carboxylate reductase, putative |
Trichomonas vaginalis | TVAG_063510 | pyrroline-5-carboxylate reductase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu506 | Mycobacterium tuberculosis | essential | nmpdr |
Tb927.7.2440 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.2440 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.2440 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.7.2440 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0386 | Escherichia coli | non-essential | goodall |
YER023W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1134200 | Plasmodium berghei | Dispensable | plasmo |
TGME49_236070 | Toxoplasma gondii | Probably non-essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Arabidopsis thaliana | Pyrroline-5-carboxylate reductase | Compounds | References |